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The natural product curacin A, a potent anticancer
agent, contains a rare cyclopropane group. The five
enzymes for cyclopropane biosynthesis are highly
similar to enzymes that generate a vinyl chloride moi-
ety in the jamaicamide natural product. The struc-
tural biology of this remarkable catalytic adaptability
is probed with high-resolution crystal structures of
the curacin cyclopropanase (CurF ER), an in vitro
enoyl reductase (JamJ ER), and a canonical curacin
enoyl reductase (CurK ER). The JamJ and CurK
ERs catalyze NADPH-dependent double bond re-
ductions typical of enoyl reductases (ERs) of the
medium-chain dehydrogenase reductase (MDR) su-
perfamily. Cyclopropane formation by CurF ER is
specified by a short loop which, when transplanted
to JamJ ER, confers cyclopropanase activity on the
chimeric enzyme. Detection of an adduct of NADPH
with the model substrate crotonyl-CoA provides
indirect support for a recent proposal of a C2-ene in-
termediate on the reaction pathway of MDR enoyl-
thioester reductases.
INTRODUCTION
The remarkable structural diversity provided by the bacterial pol-
yketides makes them pharmacologically attractive targets for
drug development (Clardy et al., 2006; Gerwick and Fenner,
2013; Gerwick and Moore, 2012; Newman and Cragg, 2012).
The unique structures of many polyketides are assembled by
multimodular type I polyketide synthases (PKSs), or by hybrid
pathways of PKS and non-ribosomal peptide synthetase mod-
ules (Fischbach and Walsh, 2006; Hertweck, 2009; Jones
et al., 2009). Polyketide biosynthesis takes place by repeated
decarboxylative condensation of acyl-coenzyme A (CoA) esters
in a process similar to that used by fatty acid synthase. Type IStructure 23, 2213–22PKS pathways operate sequentially as an ordered assembly
line of synthase modules. A minimal type I PKS module consists
of an acyltransferase to select a building block, an acyl carrier
protein (ACP) to carry the polyketide intermediate, and a keto-
synthase domain to catalyze chain extension to a b-keto inter-
mediate. Further reductive modifications of the polyketide
intermediate may result in b-hydroxyl, enoyl, or fully saturated
products through the action of ketoreductase (KR), dehydratase,
and enoyl reductase (ER) domains within the module. Onto this
canonical organization of sequential type I PKS modules, nature
has grafted domains with a variety of other catalytic activities to
create a vast number of distinct pathways that enrich the chem-
ical diversity of polyketide natural products.
The marine cyanobacterium Moorea producens (formerly
Lyngbyamajuscula; Engene et al., 2012) is a rich source of potent
anticancer and neurotoxic agents, with strains that synthesize a
number of interesting chemical groups in compounds such as
curacin A, the barbamides, and the jamaicamides (Chang
et al., 2002, 2004; Edwards et al., 2004). For example, the potent
antimitotic curacin A has a unique combination of cyclopropane,
thiazoline, cis-double bond, and terminal alkene (Chang et al.,
2004; Verdier-Pinard et al., 1999). The jamaicamides, which
block sodium channels, contain unusual groups including a vinyl
chloride and an alkynyl bromide (Edwards et al., 2004). Early
segments of the Cur and Jam biosynthetic gene clusters exhibit
high sequence identity and include a 3-hydroxy-3-methylglutaryl
(HMG)-CoA synthase-like (HCS) gene cassette encoding en-
zymes to create a b branch in the polyketide intermediate
(Figure 1A) (Calderone, 2008; Gu et al., 2006). The high-identity
regions of the cur and jam gene clusters encode a Fe2+/a-keto-
glutarate (a-KG)-dependent halogenase (Hal) and tridomain ACP
embedded in CurA and JamE; and the HMGcassette gene prod-
ucts: an HMG-ACP synthase in CurD and JamH, a dehydratase
(ECH1) in CurE and JamI, a decarboxylase (ECH2) domain
embedded in CurF and JamJ, and an ER domain embedded in
CurF and JamJ (Chang et al., 2004; Edwards et al., 2004; Gu
et al., 2006, 2009). Remarkably, the biosynthetic products of
these highly similar enzymes are a cyclopropane in curacin
and a vinyl chloride in jamaicamide. Our biochemical and struc-
tural studies have identified the enzymes and the reaction order23, December 1, 2015 ª2015 Elsevier Ltd All rights reserved 2213
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Figure 1. Parallel Biosynthetic Assembly Lines of Curacin and Jamaicamide
(A) Highly similar regions of the curacin and jamaicamide biosynthetic pathways. The HCS cassette proteins (green), triple-ACP (purple), halogenase (yellow),
enoyl reductase (red), and flanking regions (blue, brown) are shown for CurA-CurF and the homologous region in JamE-JamJ, with sequence identities given
below. KS, ketosynthase; AT, acyltransferase; Hal, halogenase; ACP, acyl carrier protein; HCS, HMG-ACP synthase; ECH1 and ECH2, enoyl-CoA hydratases; ER,
enoyl reductase.
(B) Divergence in the biosynthetic pathways of curacin A and jamaicamide A. In both pathways, CurA (or JamE) Hal chlorinates S-HMG-ACP, and CurE (or JamI)
ECH1 dehydrates the chlorinated product. The Cur and Jampathways diverge at the b-branching ECH2 step, where the CurF ECH2 forms an a-b double bond and
the Jam ECH2 a b-g double bond. The CurF ER then catalyzes cyclopropane ring formation. JamJ ER is unreactive toward the JamJ ECH2 product; however, it
reduces the CurF ECH2 product. CurK ER is a canonical PKS ER in the curacin A biosynthetic pathway, catalyzing reduction of an a-b double bond.
(C) Canonical ER reductase reaction. Hydride transfer from the cofactor NADPH to the b carbon of the unsaturated substrate is followed by protonation at the a
carbon atom.
(D) CurF ER cyclopropanation. The unique CurF ER catalyzes the NADPH-dependent nucleophilic displacement of chloride to form the strained cyclopropane
ring, presumably by a mechanism analogous to the canonical enoyl reduction (Gu et al., 2009).and have illuminated key features of the catalytic mechanisms
(Figure 1B) (Akey et al., 2012; Gu et al., 2006, 2009). In the
curacin pathway, CurA Hal produces g-chloro-HMG-ACP (com-
pound 1, Figure 1B) (Khare et al., 2010; Smith and Khare, 2015),
which is dehydrated by ECH1 to form a,b-enoyl-g-chloroglutaryl-
ACP (2) and then decarboxylated by ECH2 (Geders et al., 2007).
The analogous chemical steps in the jamaicamide and curacin
pathways are identical through ECH1 dehydration, but the path-2214 Structure 23, 2213–2223, December 1, 2015 ª2015 Elsevier Ltdways diverge at the decarboxylation step where the CurF ECH2
generates an a,b-enoyl-g-chloro-ACP product (3) and the 59%
identical JamJ ECH2 forms a b,g-enoyl-g-chloro-ACP product
(4) (Geders et al., 2007; Gu et al., 2009). The CurF ER catalyzes
formation of cyclopropane (5) in an unprecedented mechanism
involving hydride addition from NADPH and chloride elimination.
In contrast, the 65% identical JamJ ER has no apparent func-
tion in jamaicamide synthesis, as it is unreactive toward theAll rights reserved
b,g-enoyl-g-chloro-ACP JamJ ECH2 product. However, JamJ
ER functions as a reducing ER to form b-methyl-g-chlorobu-
tyryl-ACP (6) from an unnatural substrate: the CurF ECH2 prod-
uct (3) (Gu et al., 2009). The two pathways provide a prime
example of how diversification of single enzymes can lead to
different functional groups in natural product biosynthesis.
In addition to CurF ER and JamJ ER, the Cur and Jam path-
ways also include ER domains embedded within PKS modules
for enoyl reduction of polyketide intermediates: CurH ER, CurK
ER, a second ER domain within JamJ, and JamL ER. These
PKS ERs transfer a hydride ion from NADPH to the substrate
b-carbon atom (C3) and a proton to the substrate a-carbon
(C2) (Figure 1C). The CurF ER cyclopropanase also catalyzes hy-
dride transfer from NADPH. However, in this unique ER domain,
a highly strained cyclopropane ring forms upon displacement of
chloride from the substrate g-carbon atom (C4) (Figure 1D). Our
structural studies weremotivated by this unprecedented activity,
which results from modest changes at the primary sequence
level to an otherwise canonical PKS ER domain. Moreover, we
considered that the structural changes that enable generation
of the rare cyclopropane ring system would provide new insights
into subtle sequence variations that expand both chemical diver-
sity and biological activity of natural products.
The ER domains from PKS pathways belong to the medium-
chain dehydrogenase/reductase (MDR) superfamily of proteins
including metazoan fatty acid synthase ERs, quinone oxidore-
ductases, the well-studied Zn2+-dependent alcohol dehydroge-
nases (Hedlund et al., 2010; Nordling et al., 2002; Persson et al.,
2008), and a recently identified crotonyl-CoA carboxylase (Erb
et al., 2007; Quade et al., 2012). MDR reduction of thioester-
linked substrates was thought to proceed through an enolate
intermediate that formed upon hydride transfer from the nicotin-
amide C4 atom to the substrate b-carbon atom (C3). Recently a
transient ‘‘C2-ene’’ adduct between the nicotinamide C2 atom
and the thioester a-carbon (C2) was identified in two MDRs,
raising the possibility that the reaction proceeds through a
C2-ene adduct and not through an enolate (Rosenthal et al.,
2014).
Crystal structures of two PKS ERs have been reported,
including the excised cis-acting KR-ER2 didomain from the bac-
terial spinosyn (Spn) pathway (Zheng et al., 2012) and the stand-
alone trans-acting ER, LovC, from the fungal lovastatin pathway
(Ames et al., 2012); however, the structural basis of PKS enoyl
reduction remains unclear. Site-directed mutagenesis of PKS
ERs identified amino acids that may control ER stereochemistry
in the a-branched polyketides (Kwan et al., 2008), but did not
identify a proton donor for enoyl reduction (Ames et al., 2012;
Kwan and Leadlay, 2010; Zheng et al., 2012). The PKS ER struc-
tures together with a structure-based sequence alignment reveal
that a conserved proton donor does not exist in the PKS ERs.
Identification of a proton donor by mutagenesis has been a gen-
eral problem for MDR reductases and may be confounded by
buildup of a dead-end NADP-substrate C4 adduct when substi-
tutions are made at the proton donor position, as identified
recently in a fatty acid synthase ER (Rosenthal et al., 2015).
To understand the structural biology of the unprecedented
CurF ER cyclopropanase, we solved the crystal structure of
the CurF ER with bound cofactor at 0.96 A˚, as well as structures
for the homologous (65% sequence identity) JamJ ER as theStructure 23, 2213–22cofactor complex at 2.25 A˚ and in the apo form at 1.8 A˚, and
for the apo form of the canonical CurK ER reductase at 1.8 A˚.
These high-resolution structures demonstrate for the first time
that the CurF cyclopropanase is strikingly different from the
JamJ and CurK ERs in the substrate-binding region. This
enabled the design of a functionally mixed chimeric JamJ
variant that catalyzes both enoyl reduction and cyclopropana-
tion reactions on the natural curacin A substrate. Furthermore,
we assessed the possibility that one or more of the Cur/Jam
ER reactions proceeds through a C2-ene adduct and not
through an enolate. An NADP-substrate covalent adduct was
directly detected with the CurK ER reductase.
RESULTS
Overall Architecture
The CurF ER, CurK ER, and JamJ ER domains (Table 1; Figures
2, 3, S1, and S2) have the typical fold of the MDR enzyme super-
family (Hedlund et al., 2010). The ER is composed of two do-
mains (Figure 2A): a core cofactor (NADPH)-binding domain
(CurF ER amino acids 135–274) and a discontinuous substrate-
binding or catalytic domain (amino acids 1–134 and 275–337).
The most similar structures (Holm et al., 2008) in the MDR super-
family include the Spn PKS ER (PDB: 3SLK [Zheng et al., 2012];
2.1 A˚ root-mean-square deviation [rmsd], 34% identity), the hu-
man p53-inducible quinone oxidoreductase (PDB: 2J8Z [Porte
et al., 2009]; 2.8 A˚ rmsd, 24% identity), a bacterial quinone
oxidoreductase (PDB: 1QOR [Thorn et al., 1995]; 2.4 A˚ rmsd,
24% identity), and the mammalian fatty acid synthase ER
domain (PDB: 2VZ8 [Maier et al., 2008]; 2.1 A˚ rmsd, 29% iden-
tity). The trans-acting ER from the lovastatin PKS, LovC, is a
more distantly related MDR (PDB: 3B70 [Ames et al., 2012];
3.2 A˚ rmsd, 25% identity). MDR superfamily members exist pre-
dominantly as dimers or tetramers in which a continuous b sheet
forms between the nucleotide-binding domains of two subunits
through antiparallel pairing of adjacent b strands. However, in
the PKS ERs, this association is blocked by a short helix (CurF
ER a8, residues 258–265), and the ER is a monomer both in so-
lution and in crystal structures (Figure 2) (Ames et al., 2012;
Zheng et al., 2012). Apart from differences associated with
cofactor binding, the new Cur and Jam ER domain structures
are highly similar (CurF ER-NADP+ superimposes with an rmsd
of 0.7 A˚ for 271 of 332 Ca atoms of JamJ ER-NADPH, and
1.3 A˚ for 290 of 332 Ca atoms in CurK apo-ER).
Catalytic Activity
We used the CurF ER substrate to assay cyclopropane ring for-
mation by CurF ER and enoyl thioester a-b double bond reduc-
tion by JamJ ER. The natural substrate was generated by loading
a CurA ACP domain with 2-hydroxymethylglutarate, followed by
chlorination with CurA Hal, dehydration with CurE ECH1, and
decarboxylation with CurF ECH2 to generate g-chloro-b-methyl-
crotonyl-ACP (3, Figure 1B) (Geders et al., 2007; Gu et al., 2009).
Products were detected by Fourier-transform ion cyclotron reso-
nance (FT-ICR) tandemmass spectrometry (MS) (Figure 4). In the
absence of the natural CurK ER substrate (7, Figure 1B), we em-
ployed a high-performance liquid chromatography (HPLC) assay
to evaluate JamJ ER and CurK ER reduction of crotonyl-CoA to
butyryl-CoA (Figure S3). All three ER domains displayed catalytic23, December 1, 2015 ª2015 Elsevier Ltd All rights reserved 2215
Table 1. Summary of Crystal Structures
Crystal Form
CurF ER
(NADP+)
JamJ ER
(Free Enzyme)
JamJ ER
(NADPH)
Se-Met JamJ ER
(NADPH)
CurK ER
(Free Enzyme)
Diffraction Data
X-Ray source APS 23ID-D APS 23ID-D APS 23ID-B APS 23ID-D APS 23ID-B
Wavelength (A˚) 0.72932 1.0332 1.0332 0.979 1.0332
Space group C2 P1 P31 P31 F222
Cell dimensions
a, b, c (A˚) 108.9, 47.3, 76.9 50.9, 57.2, 66.1 110.7, 92.8 111.3, 91.6 93.6, 127.1, 127.8
a, b, g () b = 123.4 95.3, 106.7, 105.1
dmin (A˚) 0.96 (1.01–0.96)
a 1.80 (1.86–1.80) 2.25 (2.33–2.25) 2.6 (2.69–2.60) 1.85 (1.92–1.85)
Rmerge (%) 8.0 (66.0) 7.4 (70.2) 7.3 (60.9) 12.1 (60.5) 5.9 (62.2)
Avg. I/sI 9.5 (1.5) 14.2 (2.0) 12.3 (1.4) 25.8 (3.3) 21.0 (1.9)
Observations (n) 197,326 63,164 59,866 19,823 32,609
Completeness (%) 99.9 (94.2) 95.2 (95.8) 99.6 (99.8) 100.0 (100.0) 99.0 (100.0)
Avg. multiplicity 3.7 (2.7) 2.2 (2.2) 2.1 (2.0) 5.7 (5.8) 3.8 (3.7)
Refinement
Data range (A˚) 23.0–0.96 46.5–1.8 45.6–2.25 24.3–1.85
Reflections (n) 187,338 58,496 56,585 30,569
Rwork/Rfree (%) 11.7/13.1 18.6/22.7 17.9/21.5 18.5/22.0
No. of atoms
Protein 2,843 5,320 8,064 2,619
Water 558 414 362 230
Ligands 48 – 141 –
Rmsd
Bond lengths (A˚) 0.01 0.010 0.005 0.008
Bond angles () 1.529 1.35 1.048 1.15
Avg. B factors (A˚2)
Protein 10.3 31 39.5 35.4
NADP 8.3 – 29.3 –
Water 30.9 41 32.6 46.5
MolProbity score 1.1 1.23 1.32 1.18
MolProbity clashscore 3.06 4.55 3.66 3.94
Ramachandran plot
Favored (%) 98.92 98.07 95.96 98.8
Allowed (%) 1.08 1.1 3.74 0.9
Outliers (%) 0.0 0 0.3 0.3
Molecular State
Asymmetric unit 1 monomer 2 monomers 3 monomers 1 monomer
Active-site ligands NADP+ – NADPH –
PDB ID 5DP2 5DOV 5DOZ 5DP1
aValues in parentheses represent the highest-resolution shell.activity (Table 2; Figures 4 and S3). JamJ ER had greater activity
with the ACP-borne CurF ER substrate (3) than with crotonyl-
CoA, but with the CoA substrate JamJ ER was more active
than CurK ER.
Cofactor Binding
The NADPH cofactor binds in a narrow cleft between the cata-
lytic and nucleotide-binding domains and contacts both do-
mains through a number of hydrogen bonds and van der Waals
interactions (Figures 2B and S4) in a similar manner to NADPH2216 Structure 23, 2213–2223, December 1, 2015 ª2015 Elsevier Ltdbinding to other PKS ERs (Ames et al., 2012; Zheng et al.,
2012). The nicotinamide group is at an open end of the active-
site cleft that defines the substrate entrance. Although NADPH
was used in crystallization, the 0.96-A˚ electron density for the
nicotinamide ring was flat with no pucker at the hydride donor
(C4), indicating that oxidized NADP+ was the bound species in
the CurF ER (Figure 2B). The nicotinamide C4 is in van der Waals
contact (3.4 A˚) with the Thr140 (Thr138 in JamJ ER and CurK ER)
side-chain hydroxyl, whose position is stabilized by a hydrogen
bond to the Met136 backbone carbonyl. The fixed Thr140All rights reserved
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Figure 2. Overall Structure and Nucleotide Binding Site in CurF ER
(A) Overall structure of CurF ER. The polypeptide in the ribbon diagram is
colored as a rainbow from blue (N terminus) to red (C terminus) and secondary
structures are labeled. Cofactor NADP+ is shown as sticks with atomic colors
(white C, red O, blue N, orange P).
(B) Cofactor binding in CurF ER. The stereo view shows the environment
around the cofactor NADP+ (Fo-Fc omit map at 0.96-A˚ resolution contoured at
4s in green). NADP+ and the neighboring residues are shown as sticks (white C
in NADPH; cyan C in the protein). Hydrogen bonds are shown as black dashed
lines.position and close contact to C4 indicate that Thr140 restricts
the nicotinamide pucker of NADPH, so that C4 must pucker
away from Thr140, placing the 4-pro-R-hydride in an axial orien-
tation optimal for transfer to the substrate and the 4-pro-S-hy-
dride in an NADP+-like equatorial orientation. Thus, the Thr140
steric constraint on nicotinamide pucker provides a subtle assist
to catalysis and explains the invariance of Thr140 among PKS
ERs. Elimination of the steric constraint by mutagenesis of
Thr140 to Ala (Figures S3B and S3C, T138A) or to Val (Kwan
and Leadlay, 2010) reduced activity 3- to 4-fold. Consistent
with this hypothesis, a Val substitution for Thr in LovC resulted
in opposing effects on Km and kcat (25-fold and 35-fold, respec-
tively) with little effect on catalytic efficiency (Ames et al., 2012).
The cofactor nicotinamide is positioned by hydrogen bonds of
the amide group to backbone atoms of two ER loops (Ile251 in
the b12-a8 loop; Phe274 and Met276 in the b13-a9 loop; Fig-
ure 2B). These loops are at the substrate entrance, and also carry
conserved basic and acidic side chains that are within reach ofStructure 23, 2213–22one another but do not interact in any of the structures (CurF
Arg253, JamJ Lys251, CurK Lys250; CurF Asp275, JamJ
Asp273, CurK Asp272). We speculated that interaction of the
oppositely charged side chains may be critical to an ER state
that exists only when substrates are bound; however mutagen-
esis did not support a critical role for either amino acid in CurF,
CurK, and JamJ ERs (Table 2; Figures 4 and S3), nor in Spn
ER2, LovC ER, or ER13 of the rapamycin pathway (Ames et al.,
2012; Kwan and Leadlay, 2010; Zheng et al., 2012).
Comparison of the cofactor-bound and -free ER structures re-
veals flexibility in loops that contact NADPH, including the b11-
a7 and b12-a8 loops near the nicotinamide and the a11-b15
loop near the adenine nucleotide. Substrate binding may induce
additional changes to loops near the nicotinamide. At the other
end of the cofactor site, amino acid side chains occlude
the NADPH site in the cofactor-free JamJ (Phe45) and CurK
(His325) ER structures (Figure S2). Loop flexibility in the absence
of cofactor also explains the inability to crystallize an NADPH
complex of CurK ER, where a crystal contact trapped the a11-
b15 loop in a position that blocks the NADPH adenine nucleotide
site.
Substrate Binding and Catalysis
The three ER structures present views of an enzyme for canoni-
cal enoyl reduction (CurK ER), for cyclopropane ring formation
(CurF ER), and without natural function but possessing robust
reductase activity for the CurF ER substrate (JamJ ER) (Gu
et al., 2009). The active site of a PKS ER should bind the sub-
strate with its C3 (b) carbon near the NADPH C4 hydride donor,
and the reductases should provide a proton donor (amino acid or
water molecule) near the substrate C2 (Figure 1B). Furthermore,
the cyclopropanase must rigorously exclude proton donors from
C2 to allow formation of the strained ring. We modeled the CurF
substrate into the active site by positioning its C3 atom near the
nicotinamide C4 to identify amino acids that may be critical to
catalysis (Figure 3B). Amino acids in the active site surrounding
the nicotinamide and modeled substrate were probed by site-
directed mutagenesis of JamJ ER, CurF ER, and CurK ER. Like
others (Ames et al., 2012; Kwan and Leadlay, 2010; Zheng
et al., 2012), we found no amino acid that was essential for
reductase activity (Table 2 and Figure S3). Similarly, no single
amino acid in the CurF ER was essential for cyclopropane ring
formation.
In light of the recent identification of an unstable covalent
adduct between NADPH and an enoyl-thioester MDR substrate
(Rosenthal et al., 2014), we searched for an adduct of NADPH
with crotonyl-CoA in assays of the JamJ and CurK ERs. In reac-
tion mixes of the CurK ER D272N variant, we detected such an
adduct by HPLC, isolated it, and confirmed its existence by
MS (Figures S5A and S5B). Rosenthal and coworkers character-
ized two adducts of NADPH with crotonyl-CoA, a C2-ene (nico-
tinamide C2 to the thioester a-carbon [C2]), which is proposed to
be a catalytic intermediate, and a dead-end C4 adduct (nicotin-
amide C4 to the thioester a-carbon [C2]), which is proposed to
form when a proton donor is not available to resolve the C2-
ene. The C2-ene and C4 adducts have identical mass, but are
distinguished by UV absorbance bands at 370 nm and 328 nm,
respectively (Rosenthal et al., 2014, 2015). On this basis, CurK
ER D272N yielded the C4 adduct under the assay conditions23, December 1, 2015 ª2015 Elsevier Ltd All rights reserved 2217
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Figure 3. Comparison of ER Structures
(A) Superposition of nucleotide-binding domains. The similarity of nucleotide-binding domains and divergence of substrate-binding domains is apparent for
NADPH-bound CurF ER (cyan), JamJ ER (blue), CurK ER (yellow), and spinosyn ER2 (gray).
(B) CurF ER active site. The docked substrate (4-Cl-3-methylcrotonyl) is shown in the active site in the stereo drawing (white carbon atoms). Selected residues
tested by mutagenesis are shown in stick form in the cyan ER, with the cyclopropanase loop highlighted in magenta. The NADPH C4 atom is marked with a star,
and the active-site water is rendered as a blue sphere.
(C) Sequence alignment of the substrate loop region. The longer substrate loop of the cyanobacterial ERs is apparent.
(D) Comparison of ER substrate loops. The longer substrate loops of the JamJ and CurK ERs include a helix, which does not exist in the shorter loop of the Spn
ER2. The CurF ER cyclopropanase loop in (B) differs from the substrate loops of all canonical ERs.(Figure S5C). No adduct accumulated at levels sufficient for anal-
ysis with any other variant of CurK ER or any variant of JamJ ER.
One of the key issues relating to evolution of enzymes in sec-
ondary metabolism involves identification of specific amino acid
changes that transform catalytic function. This issue is particu-
larly relevant for the CurF ER ability to catalyze formation of a
highly strained ring system rather than the expected and typical
enoyl reduction of an a,b unsaturated acyl thioester. Interest-
ingly, substitution of CurF ER Arg253 with the more typical Lys
reduced cyclopropanation 4-fold, but the converse substitution
in JamJ ER (Lys251Arg) had no effect on reductase activity.
We also tested CurF Arg46, another conserved basic residue
near the substrate entrance that interacts with Asp275, which re-
sulted in a modest (2-fold) reduction in cyclopropane ring
formation.
The three ERs have strikingly different pockets within the cat-
alytic domain that appear tailored to the substrate length (Fig-
ure 5). The CurF ER and JamJ ER pockets are of similar size
and end near the terminal chlorine atom of the modeled sub-
strate. The CurK ER pocket is several a˚ngstro¨ms longer than
the CurF ER pocket, consistent with CurK ER substrate (7, Fig-
ure 1B), which is 15 atoms longer than the CurF ER substrate (3).
Cyclopropanase Loop and JamJ-CurF ER Chimera
The substrate-binding site is sandwiched between the NADPH
nicotinamide and a region of the catalytic domain, with the
most divergent sequence among PKS ERs (CurF ER amino acids
46–75; Figure 3C). This region, which includes helix a1 and the2218 Structure 23, 2213–2223, December 1, 2015 ª2015 Elsevier Ltdfollowing loop or helix, is about 15 amino acids longer in the
six ERs within the cyanobacterial curacin and jamaicamide path-
ways than in other bacterial cis-acting modular PKS ERs (CurF
ER 46–75 versus Spn ER2 232–247). Moreover, in this region
the CurF cyclopropanase structure differs substantially from
the JamJ and CurK reductases despite their close primary
sequence relationship to CurF ER (65% identity for JamJ ER,
51% for CurK ER) (Figures 3B–3D). Accordingly, we designated
CurF ER amino acids 54–68 as the ‘‘cyclopropanase loop.’’
Arg62 is a keystone of the cyclopropanase loop through four
hydrogen bonds of its side chain to uncharged carbonyl oxygen
atoms (Asn50 side chain and Thr74 main chain). Arg62 forms a
fifth hydrogen bond with a water molecule, which is near the Cl
atom of the modeled CurF substrate. Thus, Arg62 may stabilize
the chloride ion that forms during cyclopropanation. Consistent
with its predicted role, substitutions for Arg62 destabilized the
CurF ER protein. Only the Gln substitution yielded quasi-stable
protein, in which cyclopropane ring formation was reduced 3-
to 4-fold (Figure 4 and Table 2).
Next, we tested the function of the cyclopropanase loop by
creating a chimeric JamJ-CurF ER protein. The CurF ER cyclo-
propanase loop (amino acids 55–68) was transplanted into
JamJ ERK251R in place of amino acids 55–66 (Figures 3C and
3D). The chimeric enzyme was nearly as stable as JamJ ER
and displayed gain-of-function activity as a cyclopropanase
(Table 2 and Figure 4). Using 3-chloromethyl-crotonyl-ACP (3,
Figure 1B), the natural CurF ER substrate, we detected the for-
mation of both the reduced product (6) and the cyclopropanatedAll rights reserved
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Figure 4. Detection of ER Products by FT-ICR MS
Mass spectra for phosphopantetheine ejection products of CurF ER, JamJ ER, and the JamJ-CurF chimera. The substrate intermediates were ejected from the
ACP by collision-induced dissociation, and detected and quantified by FT-ICR MS. Calculated and observed m/z values are 343 for the cyclopropane product,
377 for the vinyl chloride, and 379 for the reduced product. Panels at the right show the isotopic distribution for the vinyl chloride and reduced products. Reactions
were performed in duplicate.product (5) at levels of about one-quarter of the total product.
No cyclopropanated product was detected from the singly sub-
stituted JamJ ERK251R (Table 2). To generate a JamJ ER chimera
even more similar to CurF ER, additional single-residue substitu-
tions were introduced at sites that contact the cyclopropanase
loop, but these uniformly led to unstable protein. Cyclopropana-
tion by the chimeric JamJ ER protein demonstrates that the
cyclopropanase loop carries the determinants of this unique
activity.
DISCUSSION
The three high-resolution crystal structures of PKS ER domains
from the cyanobacterial curacin and jamaicamide pathways illu-
minate important features of the CurF ER cyclopropanase and,
more generally, the PKS ER reductases. The ER active site,
defined by the position of bound nicotinamide, includes no
invariant amino acids, with the notable exception of a threonine
(CurF ER Thr140), whose hydroxyl group contacts the hydride-
donating C4 atom of the cofactor on the opposite side of the
nicotinamide ring from the substrate. The Thr140 side chain is
anchored in this position by a hydrogen bond of the hydroxyl
to the ER backbone. We suggest that the function of Thr140 is
to direct the nicotinamide pucker of NADPH toward the sub-
strate, placing the pro-R-hydride in an axial orientation optimal
for transfer to the b-carbon atom of the thioester substrate. An
electrostatic assist to catalysis has also been suggested for
the threonine hydroxyl group (Ames et al., 2012). Site-directed
mutagenesis of this position resulted in moderate loss of activity
(Figure S3) (Kwan and Leadlay, 2010), in accord with the pro-Structure 23, 2213–22posed conformational assist to catalysis. The threonine assist
appears to be a general feature of the MDR family, as the
same short contact of the hydroxyl to the nicotinamide C4 oc-
curs in structures of several PKS ERs (Ames et al., 2012; Zheng
et al., 2012) and other MDR enzymes (e.g., Gibbons and Hurley,
2004; Hori et al., 2006; Rosenthal et al., 2015).
Our experiments provide indirect support for the hypothesis of
a C2-ene intermediate on the reaction pathway of enoyl-thio-
ester reductases of the MDR superfamily (Rosenthal et al.,
2014). With CurK ER D272N and a crotonyl-CoA substrate, we
detected a C4 adduct (Figure S5), which had been identified pre-
viously in experiments using the C2-ene adduct as a substrate
(Rosenthal et al., 2015). It is likely that CurK ER D272N first
formed a C2-ene adduct, which spontaneously converted to
the observed C4 adduct. With an unnatural acyl group (cro-
tonyl-CoA versus 7, Figure 1B) and an unnatural carrier (CoA
versus ACP), CurK ER is a highly inefficient enzyme. The
extended reaction times required to accumulate sufficient
adduct for analysis may have been too long to detect a C2-ene
adduct. An aim of the mutagenesis experiments was to identify
the proton donor in the reductase reaction. As with other PKS
ERs, we found no amino acid to be essential to catalytic activity
(Table 2) (Ames et al., 2012; Kwan and Leadlay, 2010). Formation
of the unstable, dead-end C4 adduct, which spontaneously col-
lapses to the reduced product and NADP+, is proposed to mask
the identity of the proton donor in mutagenesis experiments
(Rosenthal et al., 2015). Our detection of the C4 adduct in
CurK ER D272N is consistent with Asp272 as the proton donor
in CurK ER. However, other possibilities cannot be excluded.
No adduct was detected in CurK ER D272A nor in analogous23, December 1, 2015 ª2015 Elsevier Ltd All rights reserved 2219
Table 2. Characterization of Products by FT-ICR MS
Cyclopropane
Product (%)
Reduced
Product (%)
Observed mass of
monoisotopic peak of
fragments (calculated
mass) (Da)
343.16 (343.16) 379.14 (379.14)
CurF ER wild-type 67 ± 2
R46A 30 ± 7
Y58A 27.4 ± 0.1
R62Q 18.5 ± 0.5
Y103A 18 ± 3
Y103F 35.3 ± 0.2
R253K 15 ± 2
D275A 28 ± 23
D275N 18
S277A 76 ± 9
S277L 23 ± 9
JamJ ER wild-type 96.9 ± 0.2
K251A 98 ± 2
K251R 100
D273A 55 ± 4
D273N 70
JamJ-CurF ER chimera 13.3 ± 0.4 47 ± 4substitutions in JamJ ER. Given the high sequence similarity
of PKS ERs, a common protein proton donor would be expected
if such exists. It is likely that the direct proton donor is a
water molecule, and that mutagenesis perturbs amino acids
that position and orient the water appropriately for proton
donation.
Several features of the structures bear on substrate selectivity.
For example, the hydrophobic acyl-binding pocket may be a
selectivity filter, as its size is correlated with the size of the sub-
strate acyl group in the CurF ER cyclopropanase and CurK ER
reductase. The pocket extends from the catalytic cleft adjacent
to the nicotinamide ring into the hydrophobic core of the sub-
strate-binding domain. A key element of substrate recognition
and selectivity is a ‘‘substrate loop’’ at the entrance to the hydro-
phobic pocket. In contrast to the other loops surrounding the
active site, which are well conserved, the substrate loop stands
out as the most variable region of PKS ER sequences. The sub-
strate loop is longer and differently structured in the cyanobacte-
rial ERs (amino acids 55–74 in CurF, CurK, and JamJ ERs)
compared with cis-acting ERs from actinomycetes PKSs (amino
acids 241–247 in Spn ER2, Figure 3C). The cyanobacterial re-
ductases, CurK ER and JamJ ER, have very similar helix-loop
structures in this region, in contrast to the analogous region of
the actinomycete Spn ER2, which consists of a much shorter,
well-ordered loop (Figure 3D). In all ER structures, the substrate
loop is anchored at both ends by hydrogen bonds from the ER
backbone to a conserved acidic side chain (Glu47 in CurF ER,
Asp47 in CurK and JamJ ERs, Asp233 in Spn ER2). This acidic
side chain was a candidate catalytic residue; however, mutagen-
esis results were consistent with disruption of the structure of the
substrate loop (Kwan and Leadlay, 2010).2220 Structure 23, 2213–2223, December 1, 2015 ª2015 Elsevier LtdA major motivation for our study was to gain new insights into
the structural basis for the remarkable cyclopropanase activity of
CurF ER, and here the substrate loop is a major player. The CurF
and JamJ ERs have a recent common ancestor, presumably a
canonical PKS ER (Gu et al., 2009). The JamJ ER is an ideal
comparative domain as it is 65% identical to CurF ER, possesses
robust reductase activity, and lacks cyclopropanase activity to-
ward the natural CurF ER substrate (3, Figure 1B). The substrate
loop of the CurF ER cyclopropanase is strikingly different from
the substrate loops of the JamJ and CurK ER reductases. On
this basis, we reasoned that this unique CurF ER loop contains
the determinants of cyclopropanase activity.
The 20-residue cyclopropanase loop has awell-ordered struc-
ture supported by at least 15 hydrogen bonds. Arg62 anchors
the loop structure through six hydrogen bonds to protein atoms.
The positively charged side chain points into the substrate-bind-
ing domain, where four of the five guanidinium protons are in
hydrogen bonds with uncharged protein oxygen atoms and the
fifth is in a hydrogen bond with a bound water, which is near
the Cl atom of the modeled CurF ER substrate. Thus, Arg62 is
ideally situated to stabilize a chloride leaving group positioned
near the bound water (3 A˚ from Arg62 NH1, 9 A˚ from nicotin-
amide C4). The lack of interaction with a formal negative charge
sets the stage for chloride ion stabilization. We also considered
the nearby Arg46 as a candidate to stabilize the chloride, as it
is highly conserved among cis-acting PKS ERs. However,
Arg62 is far more accessible than Arg46, which is further from
the modeled Cl atom and interacts with the carboxylates of
both Glu57 and Asp275. Other features of the CurF ER that pro-
mote cyclopropane formation were not apparent from our study,
in particular whether an adduct of NADPH with the substrate
might be on the reaction pathway.
The importance of the cyclopropanase loop was demon-
strated in the chimeric JamJ-CurF ER where the CurF ER loop
(amino acids 54–68) was engineered into the wild-type JamJ
protein (replacing amino acids 54–66). The chimera displayed
cyclopropanase activity with the authentic CurF ER substrate
as well as reductase activity. This result shows that in the ERs,
the substrate loop is not the sole determinant of reductase activ-
ity, as the chimera also generated the reduced product from the
authentic CurF ER substrate, an activity lacking in the wild-type
CurF ER domain (Gu et al., 2006, 2009).
In conclusion, this study provides new insights into the struc-
tural evolution of a bacterial modular PKS enoyl reductase to
catalyze a unique NADPH-dependent cyclopropanation reaction
through discrete changes to a highly variable part of the protein.
It also provides evidence for an adduct of NADPHwith the enoyl-
thioester substrate on the reaction pathway of PKS ERs.EXPERIMENTAL PROCEDURES
Cloning, Expression, and Protein Purification
The CurK ER domain (CurK amino acids 1482–1815, here referred to as 1–334)
was amplified by PCR from cosmid pLM9 (Chang et al., 2004). CurF ER (amino
acids 275–611, here 1–337) and the first ER domain within JamJ (amino acids
260–594, here 1–335) were amplified by PCR from plasmids encoding CurF ER
and JamJ ER (Gu et al., 2009). The amplified products were inserted into the
pMCSG7 (CurK ER and JamJ ER) and pMocr (CurK ER, JamJ ER, and CurF
ER) vectors and expressed in Escherichia coli BL21 (DE3) cells (DelProposto
et al., 2009; Stols et al., 2002). Cells were grown to an OD600 of 1.0 at 37
CAll rights reserved
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CurF ER JamJ ER CurK ER
Figure 5. Substrate-Binding Cavity
(A–C) The transparent gray surface represents the interior surface of the presumed substrate tunnel in CurF ER (A), JamJ ER (B), andCurK ER (C), calculated using
the program HOLLOW (Ho and Gruswitz, 2008). NADPH and the modeled CurF ER substrate are shown in stick form in the active site.in Tris-borate (Tartoff and Hobbs, 1987) supplemented with 4% glycerol, incu-
bated at 20C for 1 hr, induced with 0.4 mM isopropyl b-D-1-thiogalactopyra-
noside, and grown for an additional 20 hr. The cell pellet from a 0.5-l culture
was resuspended in 40 ml buffer A (100 mM Tris [pH 7.8], 500 mM NaCl,
5 mM imidazole, and 10% glycerol) and lysed by ultrasonication. All purifica-
tion steps were carried out at 4C. The soluble fraction was loaded onto a
HisTrap Ni2+ nitrilotriacetic acid (NTA) column (GE Healthcare), washed with
buffer A, and eluted with a linear gradient of 5–500 mM imidazole. The His6-
Mocr tag was cleaved by tobacco etch virus protease and the tag-free ER pu-
rified on a Ni2+ NTA column. Further purification was done on a Superdex 200
size-exclusion column equilibrated with buffer B (10 mM Tris [pH 7.8], 50 mM
NaCl, and 10% glycerol). Selenomethionyl-labeled JamJ ERwas purified simi-
larly to the wild-type protein, except that the pMocr:JamJ ER plasmid was
transformed into the E. coli met- auxotroph strain B834 (DE3), cells were grown
in minimal media (Molecular Dimensions), and 1 mM DTT was added in all
subsequent purification steps. All excised PKS ER domains eluted with
an apparent molecular weight of 40 kDa, corresponding to a monomer. A
JamJ-CurF ER chimera was generated by using overlap PCR to replace amino
acids 55–66 of JamJ ER with the amino acids 55–68 of CurF ER. Mutants of
CurK, JamJ, and CurF ER in the pMocr vector were generated by site-directed
mutagenesis and purified as described above.
Crystallization and Data Collection
All crystallization experiments were carried out at 20C using the sitting-drop
vapor diffusion technique. Prior to crystallization, the protein was pre-incu-
bated with NADPH (5:1 NADPH/protein) for 1 hr at 4C. A single crystal of
His6-CurK ER was obtained in 4 weeks, from a 1:1 mixture of 16 mg/ml protein
mixed with reservoir solution (1.2 M NaH2PO4, 0.8 M K2HPO4, 0.2 M Li2SO4,
and 0.1 M CAPS [pH 10.5]). Microseeding was necessary to reproduce the
His6-CurK ER crystals. JamJ ER at 6.5 mg/ml crystallized overnight from a
number of conditions in a sparse matrix screen. Further optimization using
2:1 protein/reservoir mix (20% polyethylene glycol [PEG] 3350, 0.25 M sodium
acetate, 100mMBis-Tris propane [pH 8.5]) gave the best diffracting crystals. A
second crystal form of His6-JamJ ER grew in 3 weeks from a 1:1 mixture of
protein/reservoir solution (30% PEG 4000, 0.2 M MgCl2 and 0.1 M Tris [pH
8.5]). Prior to crystallization, CurF ER was dialyzed for 3 hr against 50 mM
Tris (pH 7.8) and 100 mM NaCl to remove glycerol, and crystallized in about
5 days from a 1:1 mixture of 12 mg/ml protein with 0.1 M HEPES (pH 7.5)
and 28% PEG 3350. Crystals were cryoprotected in the corresponding reser-
voir solution with 20%glycerol (v/v) and flash-cooled in liquid nitrogen. Diffrac-
tion data were collected at 100 K on the GM/CA beamlines at the Advanced
Photon Source (Table 1). Data from CurK and JamJ ER crystals were inte-Structure 23, 2213–22grated and scaled with HKL2000 (Otwinowski and Minor, 1997). CurF ER
data consist of a high-resolution and a low-resolution pass, which were inte-
grated separately in XDS (Kabsch, 2010) and subsequently scaled together
and merged (Table 1).
Structure Determination and Refinement
CurK ER crystals belong to the orthorhombic space group F222, and the struc-
ture was solved by molecular replacement using the program BALBES (Long
et al., 2008), which used the ER domain from the mammalian fatty acid syn-
thase (PDB: 2vz9) as a starting template. The initial BALBESmodel (Rwork/Rfree
37.4%/42.6%; quality factor 0.69) was subjected to iterative rounds of manual
model building in Coot (Emsley and Cowtan, 2004) followed by refinement in
Refmac5 (Murshudov et al., 1997) in the CCP4 suite (Winn et al., 2011). The
asymmetric unit contains one molecule (VM = 2.6 A˚
3/Da, 52% solvent). Struc-
tures of the His6-JamJ ER and the tagless JamJ ER in the apo form were
solved by molecular replacement using the CurK ER structure. The His6-
JamJ ER crystals are in triclinic space group P1 with two molecules in the
asymmetric unit (VM = 2.3 A˚
3/Da, 47% solvent).
Crystals of the NADPH complex of JamJ ER appeared to be hexagonal with
Laue symmetry 6/m. However, the apparent hexagonal symmetry arises from
nearly perfect merohedral twinning of trigonal crystals following the twin law
-h, -k, l, as revealed by an H-test in phenix.xtriage (Adams et al., 2010). Molec-
ular replacement usingPhaser (McCoy et al., 2007) revealed the spacegroup to
beP31 andplaced twomolecules per asymmetric unit (A andB), corresponding
to a high VMof 4.4 A˚
3/Da and 72%solvent. Subsequent crystallographic refine-
ment stalled at Rwork of 23% and Rfree of 26%, and unoccupied weak density
suggested an additional molecule in the asymmetric unit. However, extensive
molecular replacement searches yielded no additional molecule. Ultimately,
data were collected from selenomethionine-substituted JamJ ER crystals,
and the phased anomalous differencemap clearly showedSE sites in the unas-
signed density region, corresponding to a molecule C. The twinning is ex-
plainedby thepackingofmoleculesAandB,whichare relatedbynearly perfect
61 symmetry. However, molecule C is incompatible with hexagonal symmetry
as it would clash with a 61 symmetry mate. The structure was refined with three
molecules in the asymmetric unit using the twin law (-h, -k, l) with a finalRwork of
18.5%andRfree of 20.6%.Molecule C has substantially higher atomicB factors
(average 53 A˚2) than do molecules A and B (average 33 A˚2).
The CurF ER structure was solved by molecular replacement with Phaser
using the apo form of the 65% identical JamJ ER. Refinement at 0.96 A˚ was
performed using Refmac5 with anisotropic atomic temperature factors, and
multiple side-chain conformationswere built for 33 amino acids based on elec-
tron density. jFoj  jFcj difference density was visible for 17% of the23, December 1, 2015 ª2015 Elsevier Ltd All rights reserved 2221
hydrogen atoms. Several water molecules were included with partial occu-
pancy because they are mutually exclusive with partially occupied sites of
amino acids or other water molecules. A summary of data and refinement sta-
tistics is presented in Table 1. All X-ray structures were evaluated with MolPro-
bity (Davis et al., 2007) and figures were prepared using PyMOL (Schrodinger,
2010) and LIGPLOT for protein-ligand interactions (Laskowski and Swindells,
2011).
HPLC-Based Assay to Detect Conversion of Crotonyl-CoA to
Butyryl-CoA
The 20-ml reaction mixture containing 1 mM JamJ ER (100 mMCurK ER), 1 mM
NADPH, 500 mM crotonyl-CoA, 10 mM Tris (pH 7.8), 50 mM NaCl, and 10%
glycerol was incubated for 8 min at 25C (3 hr with CurK ER), and quenched
by addition of 10 ml of 1.0 M acetic acid. Crotonyl-CoA and butyryl-CoA
were separated using reverse-phase HPLC (Agilent 1200 series) on an Eclipse
XDB-C18 column (4.6 3 150 mm). The column was run at a flow rate of 1 ml
min1, and 26 ml of sample was injected onto the column equilibrated with
5% methanol and 95% 10 mM ammonium acetate, followed by a linear
gradient to 95% methanol over 22 min. Crotonyl-CoA eluted at 8 min and bu-
tyryl-CoA at 8.6 min.
MS Analysis of NADPH Adduct with Crotonyl-CoA
HPLC purification of reaction intermediate was carried out as described in the
previous section. MS analysis on the metabolite peak eluting at 6.4 min was
performed on a Shimadzu 2010 EV APCI Spectrometer using a Luna 5-mm
C8(2) 100-A˚, 50 3 1.0-mm column (Phenomenex). The pure intermediate
was subjected to a gradient of 0%–60% methanol in 10 mM ammonium ace-
tate over 11 min. The isolated metabolite eluted at 9.2 min with the [M + 2H]2+
ion peakm/z 791.95 and the [M + 2Na]2+ ion peakm/z 813.95, consistent with
an adduct of NADPH with crotonyl-CoA (calculated mass 1,578.21 Da, m/z
789.11 for the +2 ion) from the reaction mix.
ACP-Linked Substrate and ER Activity Assay
The ACP-linked HMG substrate was generated and ER was assayed as
described previously (Gu et al., 2009). In brief, 100 mM ACP-linked substrate
was incubated sequentially with 10 mM enzymes (CurA halogenase + CurE
ECH1 + CurF ECH2) and the corresponding cofactors, at 25
C for 25 min
each. The halogenase reaction was initiated by exposing the reaction mixture
to O2. The g-chloro-b-methylcrotonyl-ACP sample was further treated with
CurF ER (100 nM) or JamJ ER (100 nM) for 5 min at 25C. The reactions
were quenched by addition of 10% formic acid (CH2O2) and the ACP-loaded
sample was separated from the reaction mix by reverse-phase HPLC using
a Source 15RPC ST4.6/100 column (GE Healthcare). The proteins were eluted
using a linear gradient from 30% to 70% of CH3CN (0.05% CF3COOH and
0.05% CH2O2)/H2O (0.05% CF3COOH and 0.05% CH2O2).
ACP Sample Analysis by FT-ICR MS
HPLC fractions were diluted at a 40:100 ratio in 50/50 HPLC-grade H2O (Ther-
moFisher Scientific) and CH3CN (ThermoFisher Scientific) with 0.1% CH2O2
(ThermoFisher Scientific). Samples were directly infused into the electrospray
source of an actively shielded 7T SolariX quadrupole FT-ICR mass spectrom-
eter (Bruker Daltonics). Data were gathered fromm/z 200–2,000 in positive ion
mode. Electrospray was conducted at 4,500 V with 128 scans per spectrum
and the transient set to 1 M data points. External ion accumulation in a hexa-
pole was 0.5 s with one ICR fill prior to excitation and detection. External
calibration utilized HP-mix (Agilent) mixed with ubiquitin (Sigma-Aldrich). Colli-
sion-induced dissociation was performed in the collision cell hexapole with
ultra-high-purity argon (Cryogenic Gases) at 10 V and all charge states present
were fragmented. Quantification was performed as previously described
(Khare et al., 2010), using the natural abundances of all isotopes.
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